The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis.
Br J Rheumatol. 1995 Apr;34(4):334-42. doi: 10.1093/rheumatology/34.4.334.
Br J Rheumatol. 1995.
PMID: 7788147
Clinical Trial.